Patrick Fabbio
CIK 1658859 · Chief Financial Officer · last filed 2026-04-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$929.3K
Companies
4
Total Filings
19
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BYSI | Director | — | $1.16 | — | $0 | 2 | 2026-04-03 |
| TARA | Chief Financial Officer | 64,115 | $3.83 | $245.6K | $0 | 8 | 2026-01-27 |
| RFL | CFO & President | 335,175 | $2.04 | $683.8K | $0 | 3 | 2022-12-23 |
| PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | CFO | — | — | — | $0 | 6 | 2020-03-04 |
Recent Filings · Page 2 of 2
19 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-12-23 | RFL | Tax (F) | −27,928 | -$49.2K | EDGAR |
| 2022-02-03 | RFL | Grant (A) | +363,103 | $0 | EDGAR |
| 2021-09-20 | RFL | Grant (A) | — | $0 | EDGAR |
| 2020-03-04 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-05 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-02 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-07 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-03 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-03 | PROGENICS PHARMACEUTICALS INC (PGNX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.